Intas Expands Its Plasma Business With A European Acquisition

Plasma-Derived Medicine Market Is Valued At $30bn

 
• By Urtė Fultinavičiūtė
  
A person holding vials of blood plasma
(Shutterstock)

More from Deals

More from Business